Paulina serves as Director Business Development & Program Management at T‑CURX, where she leads the clinical CAR‑T pipeline program TCX‑001 and drives partnering and fundraising activities. She brings more than 15 years of experience across Medical Affairs, business strategy, and CAR‑T research, including her previous role as Medical Director Cellular Therapies at Bristol Myers Squibb, where she supported the commercialization of CAR‑T therapies in lymphoma and multiple myeloma. Paulina holds a PhD in tumor immunology with a focus on CAR‑T research.